Cognitive Dysfunction in Fibromyalgia Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Rena Cooper, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01655537
First received: July 31, 2012
Last updated: September 16, 2013
Last verified: September 2013
  Purpose

Fibromyalgia is a common rheumatologic disorder. Many patients complain of cognitive dysfunction as part of their symptoms.

The investigators aim to assess this cognitive dysfunction through extensive neuro-cognitive testing.


Condition
Fibromyalgia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cognitive Dysfunction in Fibromyalgia Patients: Specific Neuro-psychological Dysfunctions, Psychiatric Comorbidity and Integrative Assessments

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Enrollment: 25
Study Start Date: July 2012
Study Completion Date: September 2013
Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

fibromyalgia patients

Criteria

Inclusion Criteria:

  1. Primary fibromyalgia as defined by the American College of Rheumatology
  2. Age 18-70 years
  3. Male or female
  4. Competent and willing to give written informed consent

Exclusion Criteria:

  1. History of head trauma
  2. Any significant neurological disorder that may confound neuro-cognitive testing
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01655537

Locations
Israel
Hadassah Medical Organization-PSYCHIATRIC CLINIC
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: RENA COOPER-KAZAZ, Dr. Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: Rena Cooper, Psychiatric Outpatient Clinic-Head, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01655537     History of Changes
Other Study ID Numbers: COG-FM-HMO-CTIL
Study First Received: July 31, 2012
Last Updated: September 16, 2013
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
fibromyalgia
cognitive dysfunction

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Cognition Disorders
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014